OptMyCare, a Dallas, TX-based provider of a clinically engineered AI healthcare & risk management platform, raised $3M in Series A funding.
The round, which brought the total amount to $4.5M, was led by LiveOak Ventures.
The company intends to use the funds to accelerate its customer acquisition plans, continuously refine its technology, onboard key management personnel, and add experienced healthcare and technology leaders.
Founded in 2019 by Dr. Antony E. Pfaffle, MD, and Dr. Saravanan Balamuthusamy, MD, MPH, FASN, FASDIN, OptMyCare is a scalable, secure, and cloud-based SaaS product that combines precision analytics with actionable risk stratification solutions across multiple chronic conditions and delivers recommendations that are based on real-time input. The product leverages clinically-engineered algorithms that take data from 55 chronic clinical diagnoses—their associated procedures and claims costs—and facilitates rapid and accurate risk identification.
FinSMEs
07/05/2024